Avid Bioservices Inc (CDMO)

[Protector]

RCJ, yes, but we were not just safe in a PII.

We were save in at least 4 PII (even if that included PII's that we do not proceed with such as Pancreatic).

We have 682 patients to en-roll and Bavi was at least safe in 400 to 450 before. That on its own is almost as much as a a full PIII under normal circumstances (as said before the FDA would never have asked for 582 patients if there would not have been the dose switching).

And Avastin, well even while Avastin is still a very harmful drug that doesn't seem to stand in the way of it being on the market. They only pulled it back for Breast Cancer. It still is cause of many internal bleeding, infections and even death.

I think, and that is my personal opinion, that Garnick has just adhered to the scenario DEC 2016 is DEC 2016. And in that scenario there is no room for any form of early 'whatever', whether it is early end of enrolment, early reporting on enrolment, early approval due to a look in, etc. Just wondering WHY!